| Literature DB >> 27439965 |
Jennifer Webb1, Allistair Abraham2.
Abstract
Advances in the fields of pediatric transfusion medicine and hematopoietic stem cell transplant have resulted in improved outcomes but also present new questions for research. The diagnostic capabilities involved in transfusion medicine have improved in recent times, now including methods for determination of red blood cell minor antigens, detection of anti-human leukocyte antigen antibodies, and noninvasive iron quantification. At the same time, transplants are being performed for more indications including nonmalignant disease and with less intense conditioning regimens that allow some recipient blood cells to persist after transplant. We are therefore faced with new opportunities to understand the implications of transfusion medicine testing and to develop data-driven guidelines relevant to the current-day approach to transfusion and transplantation.Entities:
Keywords: ABO incompatibility; Hematopoietic stem cell transplant; Pediatric; Transfusion
Mesh:
Substances:
Year: 2016 PMID: 27439965 DOI: 10.1016/j.tmrv.2016.06.002
Source DB: PubMed Journal: Transfus Med Rev ISSN: 0887-7963